Short answer · Medically reviewed summary · Last updated: 2026-04-07
Cowden syndrome is a rare, autosomal dominant genetic disorder officially classified under the umbrella of PTEN hamartoma tumor syndrome (PHTS). While it is most commonly referred to as Cowden syndrome, it is frequently identified in medical literature by various synonyms and historical names, including multiple hamartoma syndrome, reflecting its clinical presentation of widespread benign growths. What are the official and common names for Cowden syndrome? In modern clinical practice, Cowden syndrome is the standard term used to describe the condition characterized by a high risk of benign and malignant tumors, particularly in the breast, thyroid, and endometrium.
Cowden syndrome is a rare, autosomal dominant genetic disorder officially classified under the umbrella of PTEN hamartoma tumor syndrome (PHTS). While it is most commonly referred to as Cowden syndrome, it is frequently identified in medical literature by various synonyms and historical names, including multiple hamartoma syndrome, reflecting its clinical presentation of widespread benign growths.
In modern clinical practice, Cowden syndrome is the standard term used to describe the condition characterized by a high risk of benign and malignant tumors, particularly in the breast, thyroid, and endometrium. Because it is part of a spectrum of disorders caused by mutations in the PTEN gene, many clinicians now prefer the broader classification of PTEN hamartoma tumor syndrome (PHTS). Other recognized names and abbreviations include:
The variety of names for Cowden syndrome stems from its historical identification and the subsequent discovery of its genetic cause. The condition was first described in 1963 by Lloyd and Dennis, who named it after the patient, Rachel Cowden, in whom the syndrome was first identified. As our understanding of the condition evolved, medical experts realized that Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, and other related conditions were all manifestations of the same PTEN gene mutation. This led to the creation of the PHTS umbrella term to unify these related conditions under a single genetic framework for better clinical management and research consistency.
Standardized medical systems use specific identifiers to ensure consistency in patient records and research. In the Online Mendelian Inheritance in Man (OMIM) database, Cowden syndrome is cataloged under entry #158350. The Orphanet database, which tracks rare diseases globally, lists it as ORPHA205. In the ICD-10/ICD-11 coding systems, it is often coded under entries related to hereditary cancer syndromes or specific hamartomatous conditions, though these codes are updated periodically to reflect current clinical guidelines.
While Cowden syndrome remains the most clinically recognized term, you may encounter different terminology depending on the specialist you are seeing. A geneticist may refer to your diagnosis as a PTEN mutation or PHTS, while a dermatologist or oncologist might use "Cowden syndrome" to describe the specific phenotype. Currently, 116 people with Cowden syndrome have joined the DiseaseMaps.org community, where members often discuss how these different labels appear on their pathology reports and insurance documents.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified physician with any questions regarding a medical condition.